[go: up one dir, main page]

MX2014014322A - Polvos hemostaticos de celulosa oxidada regenerada y metodos de fabricacion de estos. - Google Patents

Polvos hemostaticos de celulosa oxidada regenerada y metodos de fabricacion de estos.

Info

Publication number
MX2014014322A
MX2014014322A MX2014014322A MX2014014322A MX2014014322A MX 2014014322 A MX2014014322 A MX 2014014322A MX 2014014322 A MX2014014322 A MX 2014014322A MX 2014014322 A MX2014014322 A MX 2014014322A MX 2014014322 A MX2014014322 A MX 2014014322A
Authority
MX
Mexico
Prior art keywords
making
methods
regenerated cellulose
oxidized regenerated
hemostatic powders
Prior art date
Application number
MX2014014322A
Other languages
English (en)
Other versions
MX354596B (es
Inventor
Yi-Lan Wang
Guanghui Zhang
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48537032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2014014322(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of MX2014014322A publication Critical patent/MX2014014322A/es
Publication of MX354596B publication Critical patent/MX354596B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/02—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/009—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • C08L1/04—Oxycellulose; Hydrocellulose, e.g. microcrystalline cellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Surgical Instruments (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención está dirigida a un material hemostático que contiene polvo de ORC compactado que comprende partículas que tienen una relación de aspecto promedio de aproximadamente 1 a aproximadamente 18, en donde el polvo de ORC compactado, preferentemente, se procesó en un dispositivo de compactación, tal como un polvo de ORC molido con molino de bolas; la presente invención se refiere, además, a métodos para fabricar el material hemostático y a un método para tratar una herida mediante la aplicación del polvo hemostático sobre y/o en la herida de un paciente.
MX2014014322A 2012-05-25 2013-05-22 Polvos hemostaticos de celulosa oxidada regenerada y metodos de fabricacion de estos. MX354596B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/480,842 US8815832B2 (en) 2012-05-25 2012-05-25 Oxidized regenerated cellulose hemostatic powders and methods of making
PCT/US2013/042149 WO2013177242A1 (en) 2012-05-25 2013-05-22 Oxidized regenerated cellulose hemostatic powders and methods of making

Publications (2)

Publication Number Publication Date
MX2014014322A true MX2014014322A (es) 2015-02-12
MX354596B MX354596B (es) 2018-03-12

Family

ID=48537032

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018003025A MX358625B (es) 2012-05-25 2013-05-22 Polvos hemostaticos de celulosa oxidada regenerada y metodos de fabricacion de estos.
MX2014014322A MX354596B (es) 2012-05-25 2013-05-22 Polvos hemostaticos de celulosa oxidada regenerada y metodos de fabricacion de estos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2018003025A MX358625B (es) 2012-05-25 2013-05-22 Polvos hemostaticos de celulosa oxidada regenerada y metodos de fabricacion de estos.

Country Status (16)

Country Link
US (2) US8815832B2 (es)
EP (3) EP2854882B1 (es)
JP (1) JP6165849B2 (es)
KR (2) KR102131601B1 (es)
CN (1) CN104321085B (es)
AU (1) AU2013266416B2 (es)
BR (2) BR122019014998B1 (es)
CA (2) CA3094664C (es)
DK (1) DK3466455T3 (es)
ES (2) ES2906971T3 (es)
IL (2) IL235549B (es)
IN (1) IN2014DN09514A (es)
MX (2) MX358625B (es)
RU (2) RU2696575C2 (es)
WO (1) WO2013177242A1 (es)
ZA (1) ZA201409429B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102844053B (zh) 2009-11-25 2015-08-05 洛马林达大学医学中心 基于壳聚糖的止血织物
US9259357B2 (en) 2014-04-16 2016-02-16 Loma Linda University Composition, preparation, and use of chitosan shards for biomedical applications
WO2016011315A1 (en) * 2014-07-18 2016-01-21 Ethicon, Inc. Combination cellulose material and method of making and using same
US10183132B2 (en) 2014-09-11 2019-01-22 Ethicon Llc Methods and devices for co-delivery of liquid and powdered hemostats and sealants
ES2950114T3 (es) * 2015-11-06 2023-10-05 Ethicon Inc Agregados celulósicos hemostáticos compactados
RU2731371C2 (ru) * 2015-11-08 2020-09-02 Омрикс Биофармасьютикалс Лтд. Гемостатическая смесь коротких и длинных волокон на основе целлюлозы
JP6862441B2 (ja) 2015-11-08 2021-04-21 オムリックス・バイオファーマシューティカルズ・リミテッドＯｍｒｉｘ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ． セルロース系短尺繊維及び長尺繊維の止血混合物
US20220111020A1 (en) * 2016-08-15 2022-04-14 Guangzhou Bioseal Biotech Co. Ltd. Hemostatic compositions and methods of making thereof
US11413335B2 (en) * 2018-02-13 2022-08-16 Guangzhou Bioseal Biotech Co. Ltd Hemostatic compositions and methods of making thereof
CN107754005B (zh) 2016-08-15 2021-06-15 广州倍绣生物技术有限公司 止血组合物及其制造方法
KR102656226B1 (ko) * 2016-12-09 2024-04-09 한국생산기술연구원 칼슘 카르복시메틸 셀룰로오스 파우더 및 수용성 키토산 화합물 파우더를 포함하는 지혈 소재 및 그의 제조 방법
RU2660582C1 (ru) * 2017-07-12 2018-07-06 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр гематологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ гематологии" Минздрава России) Гемостатическое покрытие в форме порошка
US11679177B2 (en) 2017-08-08 2023-06-20 Baxter International Inc. Polymeric compositions, delivery devices, and methods
US11007299B2 (en) * 2017-11-08 2021-05-18 Ethicon, Inc. Hemostatic paste having surface enriched with hemostasis-promoting agents and devices for delivery
EP3790600B1 (en) 2018-05-09 2023-12-27 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
IL262716A (en) * 2018-11-01 2018-11-29 Omrix Biopharmaceuticals Ltd Oxidized cellulose preparations
US11241386B2 (en) * 2019-02-13 2022-02-08 Biolife, L.L.C. Wound sealing powder
EP3989875A4 (en) * 2019-06-26 2023-07-26 Davol Inc. Reactive dry powdered hemostatic materials comprising a nucleophile and a multifunctional modified polyethylene glycol based crosslinking agent
AU2020312629A1 (en) 2019-07-12 2022-01-27 Gatt Technologies B.V. Haemostatic powder
JP7555981B2 (ja) 2019-07-12 2024-09-25 ガット テクノロジーズ ビー．ブイ． 組織接着性シートを調製するための方法
BR112022000511A2 (pt) 2019-07-12 2022-03-03 Gatt Tech B V Folha hemostática flexível biocompatível, embalagem vedada e método de preparação de folhas homeostáticas
WO2021014357A1 (en) * 2019-07-23 2021-01-28 Kci Licensing, Inc. Collagen-based biomaterials for wound management
IL268572A (en) 2019-08-07 2019-09-26 Omrix Biopharmaceuticals Ltd An expandable hemostatic composed of oxidized cellulose
US20210106717A1 (en) * 2019-10-10 2021-04-15 Cook Medical Technologies Llc Bonded powders for the treatment of bodily lesions
KR102886728B1 (ko) * 2019-10-31 2025-11-14 주식회사 삼양홀딩스 분말형 지혈제 조성물 및 이의 제조 방법
CN113117133B (zh) * 2019-12-31 2023-03-14 广州迈普再生医学科技股份有限公司 一种纤维聚集体及其制备方法和应用
CN113117132B (zh) * 2019-12-31 2022-11-22 广州迈普再生医学科技股份有限公司 一种可吸收膨胀式纳米短纤维粉状材料及其制备方法和应用
CN113117131B (zh) * 2019-12-31 2023-01-03 广州迈普再生医学科技股份有限公司 一种纳米纤维微球材料及其制备方法和应用
JP7721564B2 (ja) * 2020-04-17 2025-08-12 ボストン サイエンティフィック サイムド，インコーポレイテッド 止血用組成物及び関連方法
RU2756316C1 (ru) * 2020-06-15 2021-09-29 Федеральное государственное бюджетное учреждение науки Байкальский институт природопользования Сибирского отделения Российской академии наук (БИП СО РАН) Местное гемостатическое антибактериальное средство, способ его получения и медицинское изделие на его основе
US12285540B2 (en) 2020-07-21 2025-04-29 Ethicon, Inc. Hemostatic composite aggregate materials having surface enriched with hemostatis-promoting agents
CN114681660B (zh) * 2020-12-31 2023-04-18 广州迈普再生医学科技股份有限公司 可吸收止血粉及其制备方法和应用
AU2022205500A1 (en) 2021-01-08 2023-08-24 Cilag Gmbh International Bioresorbable sealing powder
US20240148933A1 (en) 2022-11-08 2024-05-09 Ethicon, Inc. Expandable hemostatic tablets comprising oxidized regenerated cellulose
GB2636872A (en) * 2023-12-29 2025-07-02 Futamura Chemical Uk Ltd Composition
US20250262343A1 (en) * 2024-02-21 2025-08-21 Solomon Rosenblatt Polymeric iodophor compositions and methods of use

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364200A (en) 1960-03-28 1968-01-16 Johnson & Johnson Oxidized cellulose product and method for preparing the same
US4626253A (en) 1984-10-05 1986-12-02 Johnson & Johnson Products, Inc. Surgical hemostat comprising oxidized cellulose
US5696191A (en) 1989-09-18 1997-12-09 Kimberly-Clark Worldwide, Inc. Surface-segregatable compositions and nonwoven webs prepared therefrom
US5180398A (en) 1990-12-20 1993-01-19 Johnson & Johnson Medical, Inc. Cellulose oxidation by a perfluorinated hydrocarbon solution of nitrogen dioxide
JP3287798B2 (ja) 1997-12-17 2002-06-04 レンゴー株式会社 球状セルロース微粒子の製造方法
RU2146264C1 (ru) * 1998-08-10 2000-03-10 Институт эколого-технологических проблем Способ получения высокоокисленной целлюлозы и высокоокисленная целлюлоза "биоакцеллин"
GB2354708B (en) 1999-10-01 2004-06-02 Johnson & Johnson Medical Ltd Compositions for the treatment of wound contracture
US6627749B1 (en) 1999-11-12 2003-09-30 University Of Iowa Research Foundation Powdered oxidized cellulose
US6309454B1 (en) 2000-05-12 2001-10-30 Johnson & Johnson Medical Limited Freeze-dried composite materials and processes for the production thereof
US6652840B1 (en) 2001-02-21 2003-11-25 Terence Prevendar Bleeding control and healing aid compositions and methods of use
US20030124087A1 (en) 2001-12-26 2003-07-03 Amitie Co. Ltd. Anti-adhesion barrier
US7279177B2 (en) 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
GB2393120A (en) 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
US20040265371A1 (en) 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
RU2377022C9 (ru) 2004-01-30 2010-08-10 Ферросан А/С Гемостатические спреи и композиции
US20070141156A1 (en) * 2005-12-21 2007-06-21 Uri Herzberg Compositions and methods for preventing or reducing postoperative ileus and gastric stasis
US20080027365A1 (en) 2006-06-01 2008-01-31 Huey Raymond J Hemostatic device with oxidized cellulose pad
GB2461019B (en) * 2008-04-25 2013-06-05 Medtrade Products Ltd Haemostatic material
JP5031054B2 (ja) * 2010-03-18 2012-09-19 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロース及びこれを含む固形製剤
US10022410B2 (en) 2010-12-22 2018-07-17 Ethicon, Inc. Hemostatic preparation containing an extract of golden moss
US9103065B2 (en) 2011-09-12 2015-08-11 Gunze Limited Method for producing hydrophilic cellulose fiber
US9028851B2 (en) 2011-12-21 2015-05-12 Ethicon, Inc. Hemostatic materials and devices with galvanic particulates
WO2016011315A1 (en) 2014-07-18 2016-01-21 Ethicon, Inc. Combination cellulose material and method of making and using same
ES2950114T3 (es) 2015-11-06 2023-10-05 Ethicon Inc Agregados celulósicos hemostáticos compactados

Also Published As

Publication number Publication date
JP6165849B2 (ja) 2017-07-19
EP3466455B1 (en) 2022-01-19
ES2906971T3 (es) 2022-04-21
MX358625B (es) 2018-08-28
RU2696575C2 (ru) 2019-08-05
KR20200085904A (ko) 2020-07-15
IL261869B (en) 2020-07-30
CA2874622A1 (en) 2013-11-28
WO2013177242A1 (en) 2013-11-28
KR20150015517A (ko) 2015-02-10
EP4043042A1 (en) 2022-08-17
CA2874622C (en) 2021-03-09
BR122019014998B1 (pt) 2020-01-28
ZA201409429B (en) 2017-04-26
IL235549B (en) 2020-03-31
ES2702714T3 (es) 2019-03-05
RU2017128652A3 (es) 2019-05-28
DK3466455T3 (da) 2022-03-14
IN2014DN09514A (es) 2015-07-17
US20130316974A1 (en) 2013-11-28
CA3094664C (en) 2023-06-06
MX354596B (es) 2018-03-12
EP2854882B1 (en) 2018-10-31
JP2015517388A (ja) 2015-06-22
CN104321085B (zh) 2017-06-23
RU2014152706A (ru) 2016-07-20
US8815832B2 (en) 2014-08-26
AU2013266416A1 (en) 2014-11-27
EP2854882A1 (en) 2015-04-08
AU2013266416B2 (en) 2016-03-24
CN104321085A (zh) 2015-01-28
KR102131601B1 (ko) 2020-07-09
EP3466455A1 (en) 2019-04-10
IL261869A (en) 2018-10-31
BR112014029206B1 (pt) 2019-11-26
US20140329769A1 (en) 2014-11-06
RU2017128652A (ru) 2019-02-04
IL235549A0 (en) 2015-01-29
US9539358B2 (en) 2017-01-10
CA3094664A1 (en) 2013-11-28
BR112014029206A2 (pt) 2017-06-27
RU2629199C2 (ru) 2017-08-25
KR102254305B1 (ko) 2021-05-24

Similar Documents

Publication Publication Date Title
MX354596B (es) Polvos hemostaticos de celulosa oxidada regenerada y metodos de fabricacion de estos.
ZA202209414B (en) Insect products and methods of manufacture and use thereof
MY179872A (en) Method for the production of commercial nanoparticle and microparticle powders
PH12013501245A1 (en) Smoke filters for smoking devices with porous masses having a carbon particle loading and an encapsulated pressure drop
MY169154A (en) Tobacco material, tobacco product to which tobacco material is added, and method for producing tobacco material
MX2016008158A (es) Metodos para dar forma a material fibroso y composiciones de tratamiento para este.
MX2016008161A (es) Metodos para dar forma a material fibroso y composiciones de tratamiento para este.
HK1221175A1 (zh) 噻托溴铵乾粉
MX2016010373A (es) Rapamicina para el tratamiento de linfangioleiomiomatosis.
NZ630367A (en) Methods of treatment of pediatric solid tumor
UA110845C2 (uk) Спосіб одержання адсорбентної частинки, яка несе ароматизатор
MY169808A (en) Plant powder-containing white chocolate-impregnated food and method for producing same
MX2017008168A (es) 1-(7,10,10-trimetil-4-biciclo [6.2.0]decanil) etanona como producto quimico aromatico novedoso.
MX346803B (es) Polvo fino de poliester alifatico de origen biologico y su metodo de preparacion.
MX2018003288A (es) Sistema y metodo para controlar la aspereza de las formulaciones en polvo seco basadas en nicotina.
NZ706983A (en) Treating soluble coffee
WO2011089130A3 (de) Verfahren zur herstellung von hohlkörpern mit eingeschlossenen frei beweglichen partikeln
MY183106A (en) Fine dry particulate retinoid active agent compostions and topical formulations including the same
MY190070A (en) Method for producing a highly porous fine powdered slaked lime composition, and product obtained therefrom
HK1209600A1 (en) Treatment of tobacco material
MX2011011157A (es) Metodo para producir particulas de polvo libre poliamida impregnada con por lo menos un agente cosmetico o farmaceutico, y particulas de polvo libre de poliamida que tienen un contenido de por lo menos 25% en peso de por lo menos un agente cosmetico
MX354460B (es) Encapsulacion de extracto en particulas porosas.
MX2014011123A (es) Composiciones y metodos de administracion oral de particulas de dietilentriaminopentaacetato encapsuladas.
MY160160A (en) Anti-wart pharmaceutical composition and method for treating wart
SG10201804347QA (en) Aqueous skin care agent

Legal Events

Date Code Title Description
FG Grant or registration